Related Experiment Video
Updated: Dec 5, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
"ASKing" the Right Questions About Screening for Celiac Disease
1School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia.
Distinguishing between symptom investigation and disease screening is crucial. A Colorado study highlights challenges in applying these principles to population-based Celiac disease screening, emphasizing patient benefit and informed follow-up.
Area of Science:
- Medical diagnostics and public health screening strategies.
Background:
- Differentiating between diagnostic testing for symptomatic individuals and screening asymptomatic populations is essential for appropriate healthcare.
- Understanding test performance characteristics in both symptomatic and asymptomatic (average or elevated risk) individuals is critical for accurate interpretation.
- Positive screening results necessitate comprehensive patient education and timely follow-up care.
Purpose of the Study:
- To clarify the distinctions between investigating symptoms and screening for disease.
- To emphasize the importance of understanding test performance in different risk groups.
- To evaluate the practical application of screening principles in population-based Celiac disease screening.
Main Methods:
- Review of diagnostic and screening principles.
- Analysis of test performance characteristics in symptomatic versus asymptomatic individuals.
- Examination of a large-scale population-based Celiac disease screening study in Colorado.
Main Results:
- Screening should offer a clear advantage to the individual, with treatment being in their best interest.
- The practical implementation of population-based Celiac disease screening presents significant challenges.
- Performance characteristics of tests differ substantially between symptomatic investigation and asymptomatic screening.
Conclusions:
- Careful consideration of patient benefit and treatment efficacy is paramount in screening programs.
- Population-based screening requires careful evaluation to ensure it is advantageous for the individual.
- The Colorado study indicates difficulties in applying established screening principles to Celiac disease on a large scale.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...